GSK-VEG105192

Study Sponsor: GSK

Study Title

A Randomised, Double-blind, Placebo controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or Metastatic Renal Cell Carcinoma

Medicine or Vaccine (generic name)

pazopanib

Sponsor Identification Number

VEG105192

Trial Registry Identification Number(#'s)

NCT00334282

Medical Condition

Carcinoma, Renal Cell

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

http://www.gsk-clinicalstudyregister.com/study/VEG105192

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00334282

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

September 2013